Slovenia is Giving in to Demands from Abroad, Lek CEO Believes

Ljubljana, 16 January - The proposed changes to the Medicinal Products and Medicinal Devices Act mean that Slovenia is "giving in to interests from abroad, which are backed by competitors from the industry and are aimed at stopping the successful breakthrough of the Slovene pharmaceutical industry to the markets of Central and Eastern Europe," said Wednesday Metod Dragonja, chairman and CEO of the pharmaceutical company Lek, after the Parliament said it would discuss the changes at an extraordinary session on Thursday.